UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000039651
Receipt No. R000045226
Scientific Title A Combined Thoracic Interfascial Plane Block for Postoperative Pain Relief and Quality of Recovery after Breast Cancer Surgery: A Prospective, Observational Cohort Study
Date of disclosure of the study information 2020/03/01
Last modified on 2020/02/29 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A Combined Thoracic Interfascial Plane Block for Postoperative Pain Relief and Quality of Recovery after Breast Cancer Surgery: A Prospective, Observational Cohort Study
Acronym A Combined Thoracic Interfascial Plane Block for Postoperative Pain Relief and Quality of Recovery after Breast Cancer Surgery: A Prospective, Observational Cohort Study
Scientific Title A Combined Thoracic Interfascial Plane Block for Postoperative Pain Relief and Quality of Recovery after Breast Cancer Surgery: A Prospective, Observational Cohort Study
Scientific Title:Acronym A Combined Thoracic Interfascial Plane Block for Postoperative Pain Relief and Quality of Recovery after Breast Cancer Surgery: A Prospective, Observational Cohort Study
Region
Japan

Condition
Condition Patients undergoing breast cancer surgery
Classification by specialty
Breast surgery Anesthesiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Chronic pain after breast cancer surgery adversely affects the patient's daily life and reduces the quality of life. As a method of preventing chronic pain after breast cancer surgery, it is adequate to relieve acute pain immediately after surgery. As a method, peripheral nerve block performed on the chest wall was reported by Blanco et al., attracting attention as a low-risk analgesic method after breast surgery. Recently, many variants of this block have been reported, and some of them have been combined to provide a broader range of analgesia.
As an evaluation of postoperative analgesia, a VAS scale or NRS scale of pain is generally used, but in recent years, an analgesic method has been evaluated from the viewpoint of the quality of recovery after the operation (Quality of Recovery). However, no effect of the combination of peripheral nerve block of the chest wall as described above on the quality of postoperative recovery, has been reported.
The primary purpose of this study is to examine the effects of a combination of chest wall peripheral nerve blocks on pain and quality of recovery after breast surgery as a prospective observational study in the acute and chronic phases (up to one year after surgery).
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes Visual Analog Scale (VAS) pain score 3 hours after surgery
Key secondary outcomes Visual Analog Scale (VAS) pain score for "morning following surgery" and "maximum until the morning after surgery."
Quality of Recovery (QoR-40; questionnaire consisting of 40 items) before and three days after surgery, 1, 3, 6, and 12 months after surgery.
Patient age, height, weight, gender
Surgery time
Total fentanyl usage, total remifentanil usage
Postoperative nausea and vomiting
Frequent use of postoperative analgesics
Time to need the first rescue analgesia
Whether there are complications associated with the block (vascular puncture, pneumothorax, hematoma, nerve damage, etc.)

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
70 years-old >=
Gender Female
Key inclusion criteria Patients undergoing breast cancer surgery at Bell Land General Hospital.
Key exclusion criteria Patients who do not agree with this study, pregnant and parturient women, allergy to local anesthetics, significant psychiatric or mental disorders, patients with chronic pain.
Target sample size 30

Research contact person
Name of lead principal investigator
1st name Toshinori
Middle name
Last name Horiuchi
Organization Bell Land General Hospital
Division name Department of Anesthesia
Zip code 599-8247
Address 500-3, Higashiyama, Naka-Ku, Sakai, Osaka
TEL 0745381023
Email thoriuch@kcn.jp

Public contact
Name of contact person
1st name Toshinori
Middle name
Last name Horiuchi
Organization Bell Land General Hospital
Division name Department of Anesthesia
Zip code 599-8247
Address 500-3, Higashiyama, Naka-Ku, Sakai, Osaka
TEL 0722342001
Homepage URL
Email t_horiuchi@seichokai.or.jp

Sponsor
Institute Department of Anesthesia, Bell Land General Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Bell Land General Hospital Institutional Review Board
Address 500-3, Higashiyama, Naka-Ku, Sakai, Osaka
Tel 0722342001
Email rib@seichokai.or.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions ベルランド総合病院(大阪府)

Other administrative information
Date of disclosure of the study information
2020 Year 03 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 30
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 03 Month 01 Day
Date of IRB
2020 Year 02 Month 20 Day
Anticipated trial start date
2016 Year 07 Month 01 Day
Last follow-up date
2020 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Observe the primary outcome, the Visual Analog Scale (VAS) pain score 3 hours after surgery, and the secondary outcomes, which are:
Quality of Recovery (QoR-40; questionnaire consisting of 40 items) before and three days after surgery, 1, 3, 6, and 12 months after surgery.
Visual Analog Scale (VAS) pain score for "morning following surgery" and "maximum until the morning after surgery."
Patient age, height, weight, gender
Surgery time
Total fentanyl usage, overall remifentanil usage
Postoperative nausea and vomiting
Frequent use of postoperative analgesics
Time to need the first rescue analgetic
Whether there are complications associated with the block (vascular puncture, pneumothorax, hematoma, nerve damage, etc.)

Management information
Registered date
2020 Year 02 Month 29 Day
Last modified on
2020 Year 02 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045226